IP Library Granted Patent US 9,695,442
Granted Patent B2
US 9,695,442 · App. 13/784,634 · Granted Jul 4, 2017

Targeted deletion of cellular DNA sequences

Inventors: Dmitry Guschin (Richmond, CA); Fyodor Urnov (Richmond, CA)
Assignee: Sangamo Therapeutics, Inc.
C12N15/85C07K14/4702C12N9/22C12N15/10C07K2319/81
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,695,442
App. No.
13/784,634
Granted
Jul 4, 2017
Kind
B2
Abstract

Disclosed herein are methods and compositions for targeted deletion of double-stranded DNA. The compositions include fusion proteins comprising a cleavage domain (or cleavage half-domain) and an engineered zinc finger domain, and polynucleotides encoding same. Methods for targeted deletion include introduction of such fusion proteins, or polynucleotides encoding same, into a cell such that two targeted cleavage events occur. Subsequent cellular repair mechanisms result in deletion of sequences between the two cleavage sites.

Claims (17)

1. A method for deleting at least 100 nucleotide pairs in a region of interest in endogenous double-stranded DNA in a plant or mammalian cell, the method comprising:

expressing first, second, third and fourth fusion proteins in the cell, each of the fusion proteins comprising:

(i) a zinc finger DNA-binding domain that binds to a target site in the endogenous DNA, and

(ii) a cleavage half-domain;

further wherein:

(a) the first and second fusion proteins bind to first and second target sites respectively, wherein a first cleavage site lies between the first and second target sites, wherein the first and second target sites, each target site comprising at least 3 target subsites, and

(b) the third and fourth fusion proteins bind to third and fourth target sites respectively, wherein a second cleavage site lies between the third and fourth target sites and wherein the first and second cleavage sites are within different sequences;

such that the first and second fusion proteins cleave the DNA at the first cleavage site, the third and fourth fusion proteins cleave the DNA at the second cleavage site, and DNA ends are rejoined such that at least 100 endogenous nucleotide pairs between the first and second cleavage sites are deleted and at least two of the target sites are maintained in the endogenous double-stranded DNA following deletion of the at least 100 endogenous nucleotide pairs.

2. The method of claim 1 , wherein the first and second cleavage sites are on the same chromosome.

3. The method of claim 1 , wherein the near edges of the first and second target sites are separated by between 4 and 6 nucleotide pairs.

4. The method of claim 1 , wherein the near edges of the third and fourth target sites are separated by between 4 and 6 nucleotide pairs.

5. The method of claim 1 , wherein at least 400 nucleotide pairs between the first and second cleavage sites are deleted.

6. The method of claim 5 , wherein at least 1000 nucleotide pairs between the first and second cleavage sites are deleted.

7. The method of claim 1 , wherein the cell is a primary cell.

8. The method of claim 7 , wherein the cell is a T-cell.

9. The method of claim 1 , wherein the first and second cleavage sites are separated by more than 100 nucleotide pairs.

10. The method of claim 1 , wherein the target site is in a CCR5 gene, β2 microglobulin gene or CTLA4 gene.

Assignments (1)
CHANGE OF NAME Recorded May 19, 2017
From: SANGAMO BIOSCIENCES, INC.
To: SANGAMO THERAPEUTICS, INC.
Reel/Frame 042506/0290 →
Continuity (10)
Continuation 11304981 · Dec 15, 2005
Continuation In Part 10912932 · Aug 6, 2004
Provisional Application 60649515 · Feb 3, 2005
Provisional Application 60493931 · Aug 8, 2003
Provisional Application 60518253 · Nov 7, 2003
Provisional Application 60530541 · Dec 18, 2003
Provisional Application 60542780 · Feb 5, 2004
Provisional Application 60556831 · Mar 26, 2004
Provisional Application 60575919 · Jun 1, 2004
Related Publication 20140065667A1 · Mar 6, 2014